SUMMARY
The mechanisms controlling differentiation in adult cardiac precursor cells (CPCs) are still largely unknown. In this study, CPCs isolated from the human heart were found to produce predominantly smooth muscle cells but could be redirected T he adult human heart has poor regenerative potential, and heart failure gradually develops following injury (1, 2) . Ultimately, heart transplantation represents the only therapeutic option for end-stage heart failure. Within this context, stimulation of cardiomyocyte production in the damaged heart to promote regeneration represents an attractive therapeutic approach (3, 4) . In (3, 4) . However, the number of CPCs in the adult myocardium is quite low, and isolation of these cells is a challenging procedure. Indeed, no truly specific markers are currently available to distinguish CPCs from other cell types (3, 4) . Multipotent mesenchymal stromal cells expressing cardiac transcription factors such as GATA4, NKX2.5, and MEF2C, but no proteins expressed by fully differentiated cardiomyocytes such as proteins of the sarcomere, could therefore be operationally defined as CPCs. Nevertheless, the effective generation of new cardiomyocytes from transferred CPCs is still a matter of intense debate, and restoration of function has been attributed to paracrine mechanisms mediated by factors secreted from the transferred cells (2) (3) (4) .
Therefore, a clear understanding of the regulatory networks controlling mobilization and differentiation of endogenous CPCs toward the cardiac lineage is required in order to facilitate the ultimate goal of cardiac regeneration.
Several pathways that are important during cardiac morphogenesis are reactivated in the damaged myocardium. Among these, the NOTCH pathway plays crucial roles in the developing and adult heart (5, 6) .
NOTCH is an evolutionarily conserved cell-to-cell communication system that takes place between 2 adjacent cells (7) . The signal-sending cell expresses a membrane-bound ligand such as Jagged (J)1, J2, Delta-like1 (DLL1), DLL3, and DLL4, and the signal-receiving cell expresses a NOTCH receptor such as NOTCH (N)1, N2, N3, and N4. Receptor engagement results in its cleavage and liberation of the NOTCH intracellular domain (NICD). NICD translocates into the nucleus, where it interacts with co-activators, in particular a transcription factor known as RBPJ, to activate target gene expression. NOTCH target genes include repressors of the Hairy enhancer of split (HES) and the related HEY families (8) . During development, NOTCH regulates trabeculation, myocyte proliferation, and valve formation. In the neonatal heart, NOTCH controls cardiac precursor expansion and differentiation (9) . In the adult heart, NOTCH signaling is activated in cardiomyocytes, CPCs, and fibroblasts (10) (11) (12) (13) (14) .
Interestingly, NOTCH appears to prevent premature cardiogenic differentiation in precursor cells, and to favor proliferation in this transient amplifying cell compartment (14) .
Consistent with this observation, blockade of the NOTCH pathway in embryonic stem cells favors commitment into the cardiac mesoderm, and subsequently, into cardiomyocytes, at the expense of the neuroectodermal lineage (15) . NOTCH signaling has also been reported to induce early cardiac commitment in embryonic and induced pluripotent stem cells, supporting a biphasic role of NOTCH in cardiogenesis (16) . Accordingly, NOTCH signaling lncRNA Isoforms Control the Fate of Human CPCs was suggested to promote cardiogenesis in the postnatal heart (17, 18) . Furthermore, NOTCH has been implicated in the differentiation of cardiospherederived cells into smooth muscle cells (19) . This finding is reminiscent of the role of NOTCH in vascular smooth muscle cells, in which Jagged1-activated NOTCH signaling promotes a differentiated phenotype (20) .
Interestingly, NICD, associated with RBPJ, binds to an enhancer within the locus encoding the small regulatory noncoding RNAs MIR-143/145, 2 microRNAs (MIRs) that were previously shown to regulate smooth muscle cell phenotype and behavior (20, 21) .
In recent years, it has become apparent that the noncoding genome is pervasively transcribed, generating thousands of long noncoding RNAs (lncRNAs). These transcripts, which are defined as being >200 nucleotides in length with no apparent protein coding potential, are typically expressed in a highly cell-and context-specific manner. LncRNAs are emerging, therefore, as master regulators of gene expression and important mediators of lineagespecific commitment during development (22, 23) . In the developing and adult hearts, lncRNAs are dynamically expressed and exert control of the cardiac gene regulatory network (24) (25) (26) . A growing body of evidence suggests that they could be pivotal during the pathophysiological response in the damaged heart (27, 28) . LncRNAs efficiently operate in cis, at the site of transcription, and in trans, at remote locations in the genome. In particular, lncRNAs, which are transcribed from active enhancers, contribute to neighboring gene activation via cis mechanisms (29, 30 specific pathogen-free conditions. CPCs were either not stimulated (None) or exposed to DLL1 for 24h. Cells Figure 1A ).
Following expansion in vitro, we routinely obtained several 100 thousand cells from each biopsy (Supplemental Table 1 ). Cells could be stored frozen, thawed, and retained a proliferative capacity for more than 15 passages. We first measured the expression of markers of cardiac specification and differentiation by RT-PCR ( Figure 1A) . Under expansion conditions, these cells expressed early cardiac markers such as GATA4, NKX2.5, and MEF2C, but no markers of differentiated cardiomyocytes such as a-myosin heavy chain (MYH6), b-myosin heavy chain (MYH7), cardiac actin (ACTA), or cardiac troponin I (TNNI). We examined cell surface marker expression by flow cytometry ( Figure 1B) . The cells uniformly expressed mesenchymal stem cell markers such as CD73, CD90, and CD105, whereas endothelial and hematopoietic markers (CD31, CD34, CD45), CD117 (KIT), CXCR4, and CD140 (PDGFRa) were not expressed. A significant proportion expressed CD146, suggesting that they could derive from pericytes (37) . However, these cells did not express NG2, another pericyte marker. The characteristics of the isolated cells were further investigated by immunostaining. All cells were found positive for NKX2.5 ( Figure 1C ). In addition, NKX2.5positive (NKX2.5 POS ) cells were MEF2C POS . The vast majority of NKX2.5 POS cells (73%) also expressed GATA4. Proliferation was examined using immunostaining directed against the proliferation markers Ki67 and phospho-Histone 3 (PH3). Respectively, 37% and 24% of NKX2.5 POS were found Ki67 POS and pH3 POS . Altogether, these data indicated that the isolated population was composed of proliferative CPCs from mesenchymal origin, which are referred throughout this paper as adult CPCs. Interestingly, adult CPCs exhibited similar characteristics as CPCs previously isolated from the human fetal heart, which were shown to produce fully differentiated cardiomyocytes (31). 
Indeed, these cells demonstrated high MYH11
expression and no expression of cardiomyocyte markers such as MYH6 and MYH7. As a consequence, the vast majority of differentiated cells were SM-MHC POS , whereas none expressed a-ACTININ.
The action of NOTCH as an inducer of cardiac commitment and proliferation is in accordance with previous observations in CPCs and immature cardiomyocytes (10, 14, 39, 40) . However, NOTCH also exerts inhibitory actions on terminal cardiac differentiation (10, 15, 40) . Therefore, while promoting CPC specification, NOTCH could at the same time block cardiomyocyte production from committed CPCs. To examine this possibility, adult CPCs were exposed to These results underlined the importance of a transient NOTCH activation to promote cardiomyocyte specification. Moreover, we formally demonstrated the dependence on the NOTCH1 signaling pathway for specifying CPCs in the cardiomyocyte lineage by taking advantage of selective inhibitory antibodies directed against N1 (namely NRR1 [41] ). Specific blockade of NOTCH1-mediated pathways in differentiating DLL1-sensitized CPCs was sufficient for producing cardiomyocytes (Supplemental Figure 3D) .
These experiments rules out nonspecific effects of DAPT in differentiating CPCs. Finally, it is important to note that CPCs exposed to a different NOTCH ligand, i.e., J1, were equally able to produce cardiomyocytes following NOTCH inhibition (Supplemental Figure 4 ). However, J1-activated CPCs did not demonstrate increased proliferation. Therefore, DLL1 was chosen for further experiments. Figure 5D ). Sarcomeric organization confirmed that transferred CPCs gave rise to mature cardiomyocytes.
Finally, we generated a tridimensional reconstruction of areas containing human cardiomyocytes, which supported functional integration of human cardiomyocytes in the mouse myocardium ( Figure 2G ).
Altogether, these data indicated that NOTCH Plaisance et al. oscillations were detected. Quantification shows the percentage of cells with spontaneous Ca 2þ activity or responding to caffeine. Abbreviations as in Figure 1 .
Plaisance et al. tion, a mechanism that is common for enhancerderived lncRNAs (30, 43) . To test this hypothesis, we designed modified antisense oligonucleotides (GapmeRs) targeting either all CARMEN isoforms or specifically CARMEN7, that is, in the latter case, the unique exon that is specific of this particular isoform. Figures 6B and 6C) . These findings confirmed the dependence of the smooth muscle lineage on CARMEN7 expression. The 2 GapmeRs alone did not, however, impact significantly cardiogenesis.
Indeed, in transfected CPCs that were not exposed to Table 2 ). We In order to define a core transcriptional program controlling differentiation into cardiomyocytes, we first identified genes commonly modulated during fetal CPC differentiation and during differentiation of adult CPCs exposed to DLL1 and DAPT. Genes that were differentially expressed in adult CPCs differentiating into smooth muscle cells were subtracted from those that were common to both datasets ( Figure 7C) .
We next determined GO category enrichment for up-and down-regulated genes. GO terms and networks associated with up-regulated genes (112 genes)
were representative of cardiac differentiation and morphogenesis, and muscle contraction. On the contrary, negatively modulated genes (37 genes) were associated with smooth muscle cell differentiation, blood vessel morphogenesis, and angiogenesis. We 
DISCUSSION
The rate of cardiomyocyte renewal in the adult mammalian heart is low, and not sufficient to replenish the heart with newly formed myocytes following injury (2) . The reasons for this relative incapacity of the heart to induce effective regeneration are still obscure. Many laboratories have identified various kinds of CPCs, which demonstrate ability to generate cardiomyocytes in vitro (3, 4) . However, these cells usually have a poor capacity to produce a functional myocardium in vivo. In the present study, we have isolated a subpopulation of multipotent clonogenic CPCs from human atrial appendages.
These cells demonstrate a unique pattern of surface marker expression. Indeed, CPC clones express uniformly CD73, CD90, and CD105, which characterize these cells as multipotent mesenchymal stromal cells.
In addition, the expression of CD146 suggest a possible pericyte origin (37) . By contrast, clones express neither NG2 nor PDGFRa (CD140a). Cardiacresident mesenchymal stromal cells that occupy a perivascular adventitial niche have been described (52) . However, these cells express PDFGRa, contrary to the adult CPCs described in our study. Moreover, this also distinguishes them from pericytes recently isolated from human ventricles (53) . Finally, these cells do not express CD117, CD31, CD34, CD45, and (9, 17, 18) . Accordingly, we show that key cardiac transcription factors such as NKX2.5, GATA4, MEF2C, and TBX5 are up-regulated in human adult CPCs exposed to DLL1, and proliferation is stimulated. This is also reminiscent of a situation observed in the heart of transgenic mice overexpressing Jagged1, in which the number of NKX2.5-positive CPCs is significantly increased (14) . Of note, NOTCH also stimulates proliferation in immature cardiomyocytes (39, 40) .
Moreover, in embryonic stem cells and in undifferentiated precursors, NOTCH is known to inhibit cardiogenesis and maturation (10, 15) . Our observation supports, therefore, the notion that NOTCH ac- is down-regulated following sequential NOTCH Provided that NOTCH is inhibited following CPC injection into the damaged myocardium, cardiomyocytes could be produced at the site of injury.
In this regard, although unspecific g-secretase inhibitors can produce toxicity in vivo, in particular in the gut, this difficulty can be overcome using selective blockers of NOTCH receptor paralogs (41) .
We have indeed tested this possibility, and demonstrated that NRR1 antibodies can substitute for DAPT during production of CPC-derived cardiomyocytes.
Finally, we recently demonstrated that CARMEN is induced in human cardiac pathologies and in mouse models of cardiac disease (32) . In this context, it would be interesting to evaluate whether manipulation of endogenous cardiogenic mesenchymal precursors in vivo via modulation of the NOTCH-CARMEN-MIR-143/145 axis is able to favor cardiomyocyte renewal in the damaged heart, and promotes true heart regeneration.
CONCLUSIONS AND LIMITATIONS
With the advent of reprogramming technologies, a novel approach to regeneration has emerged. In the context of our study, reprogramming particularly pertains to the controlled differentiation of CPCs into specific cardiac cells. Our study demonstrates that the subclass of lncRNAs that are associated to enhancer sequences can be manipulated to specify human CPCs into particular fates. Moreover, our findings suggest that the different lncRNA isoforms, lncRNA Isoforms Control the Fate of Human CPCs
